Macular fold after limited macular translocation treated with scleral shortening release and intravitreal gas.
OBJECTIVE
To describe a case developing a macular fold as a complication of limited macular translocation, which was successfully managed without repeat vitrectomy.


METHODS
Interventional case report. A 34-year-old woman who underwent limited macular translocation for subfoveal choroidal neovascularization secondary to myopic degeneration developed a postoperative macular fold. Her visual acuity deteriorated from 20/100 to 20/200 postoperatively.


RESULTS
She underwent scleral shortening release and intravitreal gas injection 4 days after the initial surgery and had a resolution of macular fold with adequate foveal displacement. Her visual acuity had improved to 20/40 3 months postoperatively.


CONCLUSIONS
Scleral shortening release and intravitreal gas injection may be considered for the management of severe macular fold caused by limited macular translocation.
Kadonosono
K
K
Department of Ophthalmology, Yokohama City University Medical Center, Yokohama, Japan. kado@med.yokohama-cu.ac.jp
Takeuchi
S
S
Iwata
S
S
Uchio
E
E
Itoh
N
N
Akura
J
J
D000328:Adult; D020256:Choroidal Neovascularization / Q000209:etiology / Q000601:surgery; D005260:Female; D005451:Fluorescein Angiography; D006801:Humans; D008266:Macula Lutea / Q000637:transplantation*; D009216:Myopia / Q000150:complications; D011183:Postoperative Complications / Q000601:surgery*; D011187:Posture; D012164:Retinal Diseases / Q000175:diagnosis / Q000209:etiology / Q000601:surgery*; D012590:Sclera / Q000601:surgery*; D013459:Sulfur Hexafluoride / Q000627:therapeutic use*; D014792:Visual Acuity
D013459:Sulfur Hexafluoride